Aptorum Group Limited , a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, today announced financial.
Aptorum Group Limited (NASDAQ:APM – Get Free Report) was the target of a significant drop in short interest in the month of April. As of April 15th, there was short interest totalling 41,000 shares, a drop of 58.4% from the March 31st total of 98,500 shares. Currently, 1.9% of the company’s shares are short sold. […]
Aptorum Group Limited (NASDAQ:APM) Sees Large Decrease in Short Interest themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Short Interest in Aptorum Group Limited (NASDAQ:APM) Decreases By 58.4% theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.